Hylomorph Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.64M

  • Investors
  • 15

Hylomorph General Information

Description

Developer of healthcare biomaterials intended to optimize the interface between implantable medical devices and biological tissues. The company's bio-engineered implants prevent postoperative complications in implantable medical devices such as fibrosis, infection, and migration, deploy advanced methods combining biotech and surface micro-engineering to promote optimal interaction between human tissues and foreign implants and first indication for use in cardiac pacemakers and defibrillators and neurostimulators, enabling doctors to improve the quality of life of patients and the quality of care by healthcare professionals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Corporate Office
  • Technoparkstrasse 1
  • 8005 Zurich
  • Switzerland

Hylomorph Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hylomorph Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 30-Apr-2023 $1.64M 000.00 Completed Clinical Trials - General
9. Later Stage VC (Series B2) 01-Jul-2023 000 000.00 0000 Completed Clinical Trials - General
8. Later Stage VC (Series B) 06-Dec-2021 00.000 000.00 000.00 Completed Clinical Trials - General
7. Accelerator/Incubator 31-Jan-2020 00.000 Completed Clinical Trials - General
6. Secondary Transaction - Private 00.000 Completed Clinical Trials - General
5. Early Stage VC (Series A) 14-Sep-2018 00.000 00.000 000.00 Completed Clinical Trials - General
4. Accelerator/Incubator 00.000 00000 Completed Startup
3. Accelerator/Incubator 000.00 00000 Completed Startup
2. Early Stage VC 22-Aug-2016 $114K $114K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Hylomorph’s complete valuation and funding history, request access »

Hylomorph Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B2 000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 515,866 $0.111098 $7 $7 1x $7 17.88%
Ordinary 111,111 $0.111098 $1.11 $1.11 1x $1.11 3.85%
To view Hylomorph’s complete cap table history, request access »

Hylomorph Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of healthcare biomaterials intended to optimize the interface between implantable medical devices and biologic
Other Devices and Supplies
Zurich, Switzerland
13 As of 2023
000.00
0000000000 000.00

0000 0

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat n
00000 0000000 000 00
West Lafayette, IN
000 As of 0000
000000&0

000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000000000000
Silver Spring, MD
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hylomorph Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cook Biotech Corporate Backed or Acquired West Lafayette, IN 000 000000&0
Elutia Formerly PE-Backed Silver Spring, MD 00 00000 000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Hylomorph Patents

Hylomorph Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4161631-A1 Insertion tool for pouches for ipgs Pending 05-Jun-2020 000000000
US-20230256255-A1 Insertion tool for pouches for ipgs Pending 05-Jun-2020 00000000000

Hylomorph Executive Team (5)

Name Title Board Seat Contact Info
Simone Bottan Ph.D Co-Founder, Chief Executive Officer, Managing Director & Board Member
Francesco Robotti Co-Founder, Chief Operating Officer & Board Member
Aldo Ferrari Chief Scientific Officer & Board Member
Sonia Schmocker Executive Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Hylomorph Board Members (6)

Name Representing Role Since
Aldo Ferrari Hylomorph Chief Scientific Officer & Board Member 000 0000
Francesco Robotti Hylomorph Co-Founder, Chief Operating Officer & Board Member 000 0000
Gian-Luigi Berini Fongit Seed Invest Board Member 000 0000
Giovanni Leo EFI Lake Geneva Ventures Chairman 000 0000
Peter Gabriel Hylomorph Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Hylomorph Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hylomorph Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Club degli investitori Angel Group Minority 000 0000 000000 0
Excellis Venture Capital Minority 000 0000 000000 0
Interconsult Corporation Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
EFI Lake Geneva Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Hylomorph FAQs

  • When was Hylomorph founded?

    Hylomorph was founded in 2014.

  • Who is the founder of Hylomorph?

    Simone Bottan Ph.D and Francesco Robotti are the founders of Hylomorph.

  • Who is the CEO of Hylomorph?

    Simone Bottan Ph.D is the CEO of Hylomorph.

  • Where is Hylomorph headquartered?

    Hylomorph is headquartered in Zurich, Switzerland.

  • What is the size of Hylomorph?

    Hylomorph has 13 total employees.

  • What industry is Hylomorph in?

    Hylomorph’s primary industry is Other Devices and Supplies.

  • Is Hylomorph a private or public company?

    Hylomorph is a Private company.

  • What is Hylomorph’s current revenue?

    The current revenue for Hylomorph is 00000.

  • How much funding has Hylomorph raised over time?

    Hylomorph has raised $15.1M.

  • Who are Hylomorph’s investors?

    Club degli investitori, Excellis, Interconsult, Horizon 2020 SME Instrument, and EFI Lake Geneva Ventures are 5 of 15 investors who have invested in Hylomorph.

  • Who are Hylomorph’s competitors?

    Cook Biotech and Elutia are competitors of Hylomorph.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »